Apraxia is a neurological disorder characterized by loss of the ability to execute or carry out skilled movements and gestures, despite having the desire and the physical ability to perform them.
Apraxia: Neurological Disorder Characterized by Difficulty in Motor Movement
- Apraxia is a neurological disorder characterized by loss of the ability to execute or carry out skilled movements and gestures, despite having the desire and the physical ability to perform them.
- Apraxia results from dysfunction of the cerebral hemispheres of the brain, especially the parietal lobe, and can arise from many diseases or damage to the brain. Milder forms of apraxia are known as dyspraxia.
- There are several kinds of apraxia, which may occur alone or together. The most common is buccofacial or orofacial apraxia, which causes the inability to carry out facial movements on command such as licking lips, whistling, coughing, or winking.
- Treatment of apraxia consists of physical, speech, and occupational therapy. If apraxia is a symptom of another disorder, the underlying disorder is treated.
Read Report Overview - https://www.transparencymarketresearch.com/apraxia-treatment-market.html
Key Drivers and Restraints of Global Apraxia Treatment Market
- Rise in prevalence of neurological disorders and growing awareness for apraxia treatment are some of the major factors responsible for the growth of global apraxia treatment market
- For instance, according to the American Speech Language Hearing Association (ASHA) data, incidence of Childhood Apraxia of Speech (CAS) is 1–10 in 1000 children or 3% to 5% of speech-impaired preschoolers in the U.S.
- Ongoing investigational therapy studies for apraxia is also a major factor fuelling the growth of the apraxia treatment market
- Growing demand for better treatment methods for apraxia disease has further boosted the growth of global apraxia treatment market
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76972
High Cost of Treatment to Hamper Market Growth
- Apraxia is one of the rare diseases which have no proper approved medications available. Treatment cost is very high due to complex mechanism for disease treatment which can hamper the market growth.
- No approved drugs are available for apraxia. This is also restraining the growth of global apraxia treatment market.
Medication to be More Promising Treatment Type Segment
- Based on treatment type, global apraxia treatment market can be divided into medication and supportive therapies
- The medication segment dominated the global market and is expected to grow at a higher CAGR due to pipeline products and growing demand for pharmacological treatment for apraxia
- The medication segment is further sub-segmented into neuromuscular blockers, antiparkinson agents, anticholinergic agents, anticonvulsants, and others
- Supportive therapies consist of speech therapy, physical therapy, and occupational therapy
Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76972
Verbal Apraxia Dominated Global Market
- In terms of type, the global apraxia market can be divided into limb apraxia, constructional apraxia, dressing apraxia, verbal apraxia, and others
- Verbal apraxia dominated the global market due to higher prevalence in children and effective therapies for childhood apraxia of speech
North America to Lead Global Market for Apraxia Treatment
- In terms of region, the global apraxia treatment market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global apraxia treatment market in 2019 due to higher reported cases of Apraxia in the region, ongoing research for effective treatment of apraxia in the region, and higher funding for rare diseases
- For instance, Apraxia Kids, a leading nonprofit organization, runs Speech Tablets for Apraxia program which has awarded nearly 700 tablets till date to children with apraxia of speech in the U.S. and Canada
- Asia Pacific is anticipated to be a highly lucrative segment during the forecast period, owing to increase in number of reported cases of apraxia in coming years, better diagnosis, and growing awareness of diseases and its treatment in the region
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=76972
Key Manufacturers Operating in global Market
Key manufacturers operating in the global market are:
- Pfizer Inc.
- Cogstate Ltd.
- Bioanalytical Systems, Inc.
- Sunovion Pharmaceuticals Inc.
- Salarius Pharmaceuticals, Inc.
- BlackThorn Therapeutics
- Otsuka Holdings Co. Ltd.
- Abide Therapeutics, Inc.
- Novartis AG
- Neurocrine Biosciences, Inc.
More Trending Reports by Transparency Market Research:
Dravet Syndrome Treatment Market: Dravet syndrome is a distressing infantile-onset epilepsy, which is sometimes accompanied by severe intellectual disabilities, autistic traits, hyperactive behavior, and ataxia. Discovery of SCN1A mutation in 2001 as a primary cause of this syndrome has accelerated the knowledge of the pathophysiological processes behind Dravet syndrome.
Overactive Bladder Treatment Market: Overactive bladder treatment includes various therapies used to treat the sudden, involuntary contraction of the muscle in the urinary bladder wall. This contraction leads to urgency to urinate, risen frequency of urinating, nocturia, and urge-incontinence. Overactive bladder treatment involves several approaches ranging from medication to behavioral changes as well as a combination of both medication and behavioral changes.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453